Nausea-Induced 5-HT Release in the Interoceptive Insular Cortex and Regulation by Monoacylglycerol Lipase (MAGL) Inhibition and Cannabidiol.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

20 citing papers in PubMed, 39 citations in OpenAlex.

1. The Potential of Cannabidiol for the Treatment of Psychosis: Endocannabinoid Regulation of Serotonergic Neurotransmission via Serotonin 5-HT1A/2A Receptors.Neurochemical research · 2026
   Review
2. Enhanced disgust generalization in obsessive-compulsive disorder is related to insula and putamen hyperactivity.Psychological medicine · 2025
   Article
3. Endocannabinoid signaling in stress, nausea, and vomiting.Neurogastroenterology and motility · 2025
   Review
4. The Polypharmacological Effects of Cannabidiol.Molecules (Basel, Switzerland) · 2023
   Review
5. Social factors and the neurobiology of pathogen avoidance.Biology letters · 2022
   Review
6. Cannabidiol Interferes with Establishment of ΔCannabis and cannabinoid research · 2022
   Article
7. On the Biomedical Properties of Endocannabinoid Degradation and Reuptake Inhibitors: Pre-clinical and Clinical Evidence.Neurotoxicity research · 2021
   Review
8. Cannabinoids and Cancer Chemotherapy-Associated Adverse Effects.Journal of the National Cancer Institute. Monographs · 2021
   Article
9. Therapeutic Potential of Cannabidiol, Cannabidiolic Acid, and Cannabidiolic Acid Methyl Ester as Treatments for Nausea and Vomiting.Cannabis and cannabinoid research · 2021
   Review
10. Activation of PPG neurons following acute stressors differentially involves hindbrain serotonin in male rats.Neuropharmacology · 2021
    Article
11. Cannabidiol and Neurodevelopmental Disorders in Children.Frontiers in psychiatry · 2021
    Review
12. Spontaneous and Naloxone-Precipitated Withdrawal Behaviors From Chronic Opiates are Accompanied by Changes inFrontiers in pharmacology · 2021
    Article
13. Pathogens, odors, and disgust in rodents.Neuroscience and biobehavioral reviews · 2020
    Review
14. Evaluation of repeated or acute treatment with cannabidiol (CBD), cannabidiolic acid (CBDA) or CBDA methyl ester (HU-580) on nausea and/or vomiting in rats and shrews.Psychopharmacology · 2020
    Article
15. Antiemetic Effects of Cannabinoid Agonists in Nonhuman Primates.The Journal of pharmacology and experimental therapeutics · 2020
    Article
16. Oleoyl alanine (HU595): a stable monomethylated oleoyl glycine interferes with acute naloxone precipitated morphine withdrawal in male rats.Psychopharmacology · 2020
    Article
17. Role of the stress response and the endocannabinoid system in ΔPsychopharmacology · 2020
    Article
18. Nausea and Vomiting Not Related to Cancer Therapy: Intractable Problem or Clinical Challenge?Journal of the advanced practitioner in oncology · 2020
    Review
19. Effect of combined doses of ΔPsychopharmacology · 2020
    Article
20. The Interplay between the Endocannabinoid System, Epilepsy and Cannabinoids.International journal of molecular sciences · 2019
    Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

4 authors at 2 institutions in 1 country.

Funding

Abstract

Indexed as